Virus de la gripe
Los inhibidores del virus de la gripe son compuestos que interfieren con la replicación y propagación de los virus de la gripe. Estos inhibidores son vitales en la investigación de estrategias antivirales, la comprensión del ciclo de vida del virus de la gripe y el desarrollo de tratamientos y vacunas eficaces. Los inhibidores de la gripe pueden dirigirse a varias etapas del proceso de replicación viral, incluyendo la entrada viral, la replicación y la liberación. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad del virus de la gripe para apoyar su investigación en virología, enfermedades infecciosas y desarrollo de medicamentos antivirales.
Se han encontrado 296 productos de "Virus de la gripe"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Z-VRPR-FMK TFA
<p>Z-VRPR-FMK (TFA), a tetrapeptide, irreversibly inhibits MALT1, protecting against influenza A.</p>Fórmula:C33H50F4N10O8Forma y color:SolidPeso molecular:790.81Neuraminidase-IN-16
<p>Neuraminidase-IN-16 (43b) inhibits H5N1, H5N8, H1N1, H3N2, H5N1-H274Y, H1N1-H274Y neuraminidases; IC50: 0.031-10.08 μM.</p>Fórmula:C26H35FN2O4Forma y color:SolidPeso molecular:458.57Neuraminidase-IN-22
<p>Neuraminidase-IN-22 (compound 3e) serves as a potent, selective, and orally active inhibitor of neuraminidase, exhibiting a low IC 50 value of 0.03 µM. This compound demonstrates cytotoxic effects and possesses activity against the influenza A virus.</p>Fórmula:C17H13FN2O2Forma y color:SolidPeso molecular:296.3Influenza A NP(366-374) Strain A/PR/8/35
CAS:<p>This peptide is an H2-Db-restricted epitope from the Influenza A/PR/8/34 nucleoprotein.</p>Fórmula:C38H63N11O18S2Pureza:98%Forma y color:SolidPeso molecular:1026.1CEF1, Influenza Matrix Protein M1 (58-66)
CAS:<p>CEF1, M1 (58-66) epitope from influenza A; GILGFVFTL is HLA-A2-restricted.</p>Fórmula:C49H75N9O11Pureza:98%Forma y color:SolidPeso molecular:966.17PA (224-233), Influenza
CAS:PA (224-233), Influenza is a 10-aa peptide, which is a fragment of polymerase 2 protein in Influenza a virus.Fórmula:C53H80N14O17Pureza:98%Forma y color:SolidPeso molecular:1185.29Influenza NP (147-155)
CAS:<p>This peptide is a H-2Kd-restricted epitope from Influenza nucleoprotein (147-155).</p>Fórmula:C48H82N16O14Pureza:98%Forma y color:SolidPeso molecular:1107.26Neuraminidase-IN-12
CAS:<p>NDV-IN-1 is an antiviral inhibiting neuraminidase and the Newcastle disease virus, preventing virion release from Vero cells.</p>Fórmula:C11H13F3N4O7Forma y color:SolidPeso molecular:370.24Anti-IAV agent 1
<p>Anti-IAV agent 1 -1a: Orally active, fights influenza A. IC50: 0.03μM for H1N1, 0.06μM for resistant strains.</p>Fórmula:C28H28FN9O3Forma y color:SolidPeso molecular:557.58PROTAC Hemagglutinin Degrader-1
<p>PROTAC Hemagglutinin Degrader-1 (V3) degrades influenza HA potently (DC50 1.44 μM) with broad-spectrum antiviral effects.</p>Fórmula:C61H93N5O9SForma y color:SolidPeso molecular:1072.48A-315675
CAS:<p>A-315675 is a neuramidase inhibitor with anti-infuenza activity.</p>Fórmula:C17H30N2O4Forma y color:SolidPeso molecular:326.431-Deoxymannojirimycin hydrochloride
CAS:<p>1-Deoxymannojirimycin hydrochloride is a selective α1,2-mannosidase inhibitor(IC50: 20 μM).</p>Fórmula:C6H14ClNO4Pureza:98%Forma y color:SolidPeso molecular:199.63RdRP-IN-8
<p>RdRP-IN-8 (compound 45) is an antiviral agent targeting influenza viruses. It inhibits the viral RNA-dependent RNA polymerase (RdRP) activity by disrupting the heterodimerization of the PA and PB1 subunits, with an IC50 value of 0.13 μM.</p>Fórmula:C23H21N3O6SForma y color:SolidPeso molecular:467.49Dihydromaniwamycin E
<p>Dihydromaniwamycin E is a heat-shock metabolite exhibiting antiviral activity against influenza and SARS-CoV-2 viruses [1].</p>Fórmula:C10H22N2O2Forma y color:SolidPeso molecular:202.29Influenza HA (307-319)
CAS:<p>Influenza Hemagglutinin is an HLA-DRB 0101-restricted epitope from influenza hemagglutinin (307-319).</p>Fórmula:C69H118N18O19Pureza:98%Forma y color:SolidPeso molecular:1503.78VIR-7229
<p>VIR-7229 is a human IgG1 monoclonal antibody that targets the Receptor-Binding Domain (RBD) of the Spike glycoprotein. It exhibits antiviral activity by competing with ACE2 for binding and inducing the shedding of the S1 protein. VIR-7229 is applicable for research on SARS-CoV-2 infections. Recommended isotype control: Human IgG1 kappa, Isotype Control.</p>Forma y color:Odour LiquidCletoquine hydrochloride
CAS:<p>Cletoquine hydrochloride, a Hydroxychloroquine metabolite, is a Chloroquine derivative with antimalarial properties and combatting CHIKV.</p>Fórmula:C16H23Cl2N3OPureza:99.98%Forma y color:SoildPeso molecular:344.28BCX-1898
CAS:<p>BCX-1898: Oral cyclopentane-based neuraminidase inhibitor for flu A/B; EC50 <0.01-21µM; effective in mouse models.</p>Fórmula:C17H32N4O3Forma y color:SolidPeso molecular:340.46HAA-09
CAS:<p>HAA-09: oral anti-influenza with EC50 of 0.03μM; inhibits PB2, IC50 0.06μM; non-toxic, blocks virus replication.</p>Fórmula:C17H18F2N6O2Forma y color:SolidPeso molecular:376.36Influenza A virus-IN-1
CAS:<p>Influenza A virus-IN-1, a dihydropyrrolidone, blocks IAV subtypes (IC50: 3.11-7.13 μM), boosts IFN-β and MxA antivirals.</p>Fórmula:C27H20F6N2O3Forma y color:SolidPeso molecular:534.458
